News
LJUIF
0.540
NaN%
--
SSY Group Sets Board Meeting to Approve Interim Results and Consider Dividend
TipRanks · 1d ago
SSY Group Wins China Approval for New Antipsychotic Bulk Drug
TipRanks · 08/07 11:15
SSY Group Wins NMPA Approvals for Four New Drugs, Bolsters Ophthalmic and ICU Portfolios
TipRanks · 08/06 08:47
SSY Group Wins Full Slate of Bids in China’s 12th National Drug Procurement Round
TipRanks · 08/03 10:11
SSY Group Wins NMPA Approval for New Gastrointestinal and Respiratory Drugs
TipRanks · 07/30 08:40
SSY Group Wins Approval for Four New Drugs, Expands Critical Care and Ophthalmic Portfolio
TipRanks · 07/23 08:39
SSY Group Wins China Approval for Next-Generation MRI Contrast Agent Gadobutrol
TipRanks · 07/21 00:07
SSY Group Wins China Approval for Next-Generation Lipid-Lowering Capsule
TipRanks · 07/16 04:37
SSY Group Wins NMPA Approval for Baloxavir Marboxil Bulk Drug in China
TipRanks · 07/13 04:07
SSY Group Gains New NMPA Approvals for Hyperthyroidism and Calcium Therapies
TipRanks · 07/10 08:38
SSY Group Gains Major Boost as 95 Drugs Enter China’s 2026 Essential Medicines List
TipRanks · 07/10 04:07
SSY Group Wins NMPA Approvals for Methocarbamol Tablets and Phloroglucinol Bulk Drug
TipRanks · 07/02 00:07
SSY Group Expands Restricted Share Award Pool with Market Purchase
TipRanks · 06/26 08:40
SSY Group Buys Back 1 Million Shares for Restricted Award Scheme
TipRanks · 06/25 09:10
SSY Group Boosts Share Award Pool with Open-Market Purchase
TipRanks · 06/24 09:39
SSY Group Buys Back 2 Million Shares for Employee Award Scheme
TipRanks · 06/23 09:11
SSY Group Wins NMPA Approvals for Parkinson’s and Respiratory Drugs
TipRanks · 06/22 04:07
SSY Group Adds Shares to Restricted Award Scheme via Market Purchase
TipRanks · 06/17 09:13
SSY Group Expands Pool of Shares for Restricted Award Scheme via Market Purchase
TipRanks · 06/16 09:09
SSY Group Wins China Approval for New Cefpodoxime Suspension
TipRanks · 06/16 00:37
More
Webull provides a variety of real-time LJUIF stock news. You can receive the latest news about Ssy Group through multiple platforms. This information may help you make smarter investment decisions.
About LJUIF
SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.